Editöre Mektup

Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis

Cilt: 10 Sayı: 02 29 Kasım 2020
  • Veronica Salazar *
  • Laura Aragon
  • Lilian Abbo
Journal of Microbiology and Infectious Diseases Kapak
Journal of Microbiology and Infectious Diseases
PDF İndir
EN

Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis

Abstract

Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis. J Microbiol Infect Dis 2020; 10(2): 106-107.

Keywords

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Editöre Mektup

Yazarlar

Veronica Salazar * Bu kişi benim
United States

Laura Aragon Bu kişi benim
United States

Lilian Abbo Bu kişi benim
United States

Yayımlanma Tarihi

29 Kasım 2020

Gönderilme Tarihi

28 Haziran 2019

Kabul Tarihi

30 Nisan 2020

Yayımlandığı Sayı

Yıl 2020 Cilt: 10 Sayı: 02

DOI

https://doi.org/10.5799/jmid.748739

IZ

https://izlik.org/JA58KH84YA

Kaynak Göster

RIS / Bibtex
APA
Salazar, V., Aragon, L., & Abbo, L. (2020). Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis. Journal of Microbiology and Infectious Diseases, 10(02), 106-107. https://doi.org/10.5799/jmid.748739
AMA
1.Salazar V, Aragon L, Abbo L. Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis. Journal of Microbiology and Infectious Diseases. 2020;10(02):106-107. doi:10.5799/jmid.748739
Chicago
Salazar, Veronica, Laura Aragon, ve Lilian Abbo. 2020. “Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis”. Journal of Microbiology and Infectious Diseases 10 (02): 106-7. https://doi.org/10.5799/jmid.748739.
EndNote
Salazar V, Aragon L, Abbo L (01 Kasım 2020) Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis. Journal of Microbiology and Infectious Diseases 10 02 106–107.
IEEE
[1]V. Salazar, L. Aragon, ve L. Abbo, “Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis”, Journal of Microbiology and Infectious Diseases, c. 10, sy 02, ss. 106–107, Kas. 2020, doi: 10.5799/jmid.748739.
ISNAD
Salazar, Veronica - Aragon, Laura - Abbo, Lilian. “Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis”. Journal of Microbiology and Infectious Diseases 10/02 (01 Kasım 2020): 106-107. https://doi.org/10.5799/jmid.748739.
JAMA
1.Salazar V, Aragon L, Abbo L. Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis. Journal of Microbiology and Infectious Diseases. 2020;10:106–107.
MLA
Salazar, Veronica, vd. “Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis”. Journal of Microbiology and Infectious Diseases, c. 10, sy 02, Kasım 2020, ss. 106-7, doi:10.5799/jmid.748739.
Vancouver
1.Veronica Salazar, Laura Aragon, Lilian Abbo. Intravenous Fosfomycin for Treatment of Refractory Stenotrophomonas maltophilia Ventriculitis. Journal of Microbiology and Infectious Diseases. 01 Kasım 2020;10(02):106-7. doi:10.5799/jmid.748739